Physician profile
Lauren E Haag
NPI 1699397067
$896.94
in general payments reported to CMS, 2019-2025
12 companies · $609 in 2025
The $609 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $287 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $480.00 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Medtronic, INC. | $151.44 | 2025 | Intellis Adaptivestim, Symplicity G3 |
| Novo Nordisk INC | $49.95 | 2024-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $46.49 | 2024-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Cranial Technologies, INC | $41.44 | 2024-2025 | Doc Band |
| Pfizer INC. | $31.03 | 2025 | |
| Vanda Pharmaceuticals INC. | $24.14 | 2025 | Fanapt |
| Glaxosmithkline, LLC. | $15.35 | 2024 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.99 | 2024 | Jardiance |
| Sumitomo Pharma America, INC. | $14.28 | 2025 | Gemtesa |
| Amgen INC. | $14.19 | 2025 | Evenity |
| Novartis Pharmaceuticals Corporation | $13.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Haag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.